These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32614130)

  • 1. Simultaneous response of cutaneous and lung squamous cell carcinoma with cemiplimab.
    Escobar GF; Granel-Brocard F; Schmutz JL; Cervantes P; Ben Mahmoud S; Bursztejn AC
    Dermatol Ther; 2020 Nov; 33(6):e13951. PubMed ID: 32614130
    [No Abstract]   [Full Text] [Related]  

  • 2. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
    Migden MR; Khushalani NI; Chang ALS; Lewis KD; Schmults CD; Hernandez-Aya L; Meier F; Schadendorf D; Guminski A; Hauschild A; Wong DJ; Daniels GA; Berking C; Jankovic V; Stankevich E; Booth J; Li S; Weinreich DM; Yancopoulos GD; Lowy I; Fury MG; Rischin D
    Lancet Oncol; 2020 Feb; 21(2):294-305. PubMed ID: 31952975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
    Konidaris G; Paul E; Kuznik A; Keeping S; Chen CI; Sasane M; Xu Y; Atsou K; Ayers D; Ruiz ES; Khushalani NI; Cope S
    Value Health; 2021 Mar; 24(3):377-387. PubMed ID: 33641772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous squamous cell carcinoma presenting with facial paralysis: good response to Cemiplimab.
    Estenaga A; Castañón E; García-Martínez FJ; Redondo P
    J Dtsch Dermatol Ges; 2021 Mar; 19(3):448-450. PubMed ID: 32930485
    [No Abstract]   [Full Text] [Related]  

  • 5. Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma.
    Lee A; Duggan S; Deeks ED
    Drugs; 2020 Jun; 80(8):813-819. PubMed ID: 32306208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cemiplimab-rwlc in advanced cutaneous squamous cell carcinoma: real-world experience in a French dermatology department.
    Guillaume T; Puzenat E; Popescu D; Aubin F; Nardin C
    Br J Dermatol; 2021 Nov; 185(5):1056-1058. PubMed ID: 34107076
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiation recall during cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma.
    Vaccaro M; Bertino L; Santarpia M; Altavilla G; Cannavò SP
    Dermatol Ther; 2020 Nov; 33(6):e14417. PubMed ID: 33068047
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel treatment of locally advanced cutaneous squamous cell carcinoma with cemiplimab: a case report.
    Nelson R; Luu L; Silberstein P; Velagapudi M; Huerter C
    Int J Dermatol; 2021 Feb; 60(2):233-235. PubMed ID: 32955136
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful Administration of Cemiplimab to a Patient With Advanced Cutaneous Squamous Cell Carcinoma After Renal Transplantation.
    Ali SA; Arman HE; Patel AA; Birhiray RE
    JCO Oncol Pract; 2020 Mar; 16(3):137-138. PubMed ID: 31770056
    [No Abstract]   [Full Text] [Related]  

  • 10. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
    Migden MR; Chandra S; Rabinowits G; Chen CI; Desai J; Seluzhytsky A; Sasane M; Campanelli B; Chen Z; Freeman ML; Ibrahim SF; Khushalani NI; Andria M; Ruiz E
    Future Oncol; 2020 Feb; 16(4):11-19. PubMed ID: 31951149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of cemiplimab in progressive metastatic cutaneous squamous cell carcinoma after kidney transplantation: a case report.
    Geidel G; Rünger A; Schneider SW; Gebhardt C
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():49-52. PubMed ID: 34855252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ulcers and sarcoid-like reaction in lymph nodes after cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma: a case report.
    Ferreira MH; Bezinelli LM; Eduardo FP; Gobbi MF; Corrêa L; Schvartsman G
    Einstein (Sao Paulo); 2022; 20():eRC6367. PubMed ID: 35303053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme.
    Challapalli A; Watkins S; Cogill G; Stewart G; Ellis S; Sykes A; Nobes J; Yip K; Barthakur U; Board R; Gadve A; O'Toole L; Kent C; Mackenzie J; Papa S; Fusi A; Fife K
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e590-e592. PubMed ID: 35298050
    [No Abstract]   [Full Text] [Related]  

  • 14. Cemiplimab and ruxolitinib in concomitant cutaneous squamous cell carcinoma and myelofibrosis.
    Di Raimondo C; Rao L; Lozzi F; Lombardo P; Silvaggio D; Vellucci L; Tofani L; Campione E; Bianchi L
    Dermatol Ther; 2022 May; 35(5):e15421. PubMed ID: 35249252
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis.
    Pham JP; Sivasubramaniam V; Gallagher R; Forstner D; Wong M; Liu J
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e363-e365. PubMed ID: 36226470
    [No Abstract]   [Full Text] [Related]  

  • 16. Unresectable auricular squamous cell carcinoma with locoregional metastasis: use of cemiplimab in an immunosuppressed patient.
    França TF; Gontijo JRV; Junior EFV; Lima EM
    An Bras Dermatol; 2024; 99(1):158-160. PubMed ID: 37652819
    [No Abstract]   [Full Text] [Related]  

  • 17. Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma.
    Ahmed SR; Petersen E; Patel R; Migden MR
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):947-951. PubMed ID: 31524530
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance of clinical response after short treatment with cemiplimab for advanced squamous cell carcinoma.
    Conforti C; Toffoli L; Agozzino M; Fedele D; Moroso S; di Meo N; Zalaudek I
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e443-e445. PubMed ID: 35037322
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged Response to Pembrolizumab in Spindle Cell Squamous Cell Carcinoma Metastatic to the Central Nervous System.
    Liu Y; Fitzgerald B; Perry E; Pathak A; Chao HH
    J Investig Med High Impact Case Rep; 2019; 7():2324709619850216. PubMed ID: 31132886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
    Hernández-Guerrero T; Doger B; Moreno V
    Drugs Today (Barc); 2019 Aug; 55(8):485-494. PubMed ID: 31461085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.